The following section covers the peptides with the most substantive research behind their antidepressant properties, presented in order of evidence strength and mechanistic interest
King MA, Bradshaw S, Chang AH, Pintar JE, Pasternak GW
To watch for and immediately report signs of hypervitaminosis A, manifested by nausea, vomiting, headache, dizziness, blurred vision, if patients have renal impairment
Any company that aspires to prove the safety and effectiveness of a peptide will turn away from them, knowing that compounders will simply be able to sell them without ever needing to generate safety and effectiveness evidence. Indeed, Lurie continued, financial analysts are predicting a $2.2 billion telehealth marketing opportunity if these seven peptides are approved for compounding
See more Carbonic anhydrase inhibitors dorzolamide and brinzolamide, when administered topically in the eye, are not prohibited
Interest in experimental peptides has boomed in recent years